journal article·2026-07Open access

Metabolic Imbalance Triggers Adaptive Remodeling to Accelerate Diploidization in Murine Haploid Embryonic Stem Cells

Yi Fu, Wenhao Zhang, Yifan Zhang, Yu He, Yi Du, Yiding Zhao, Chunmeng Yao, Shengyi Sun, Xiaoyan Sheng, Qian Gao, Chao Tong, Ling Shuai

Advanced Science· Volume 13· Issue 40

Abstract

ABSTRACT Murine haploid embryonic stem cells (haESCs) are ideal tools for functional genetics analyses because of their single‐genome stem cell features. However, self‐diploidization severely restricts their broader application. Although numerous attempts have been made to prevent diploidization, an effective and reliable strategy is lacking. In this study, we performed multiomics comparative analyses between haESCs and their diploidized counterparts (Di‐haESCs), which revealed that metabolic remodeling induced the adaptive evolution of haESCs toward a diploid state. Notably, an overload of intramitochondrial ROS in haESCs impaired mitochondrial bioenergetics, increasing their susceptibility to cell death and driving the progressive accumulation of diploidized cells in culture. We further found that a disrupted pyruvate–lactate balance in haESCs led to altered tricarboxylic acid (TCA) cycle activity, which was closely linked to mitochondrial dysfunction and haploid instability. Leveraging the recovery of mitochondrial function and a doubled mitochondrial number after diploidization, we performed a genome‐wide screening to identify key mitochondrial quality control (MQC) genes involved in this process. On the basis of these mechanistic insights, we developed a metabolically optimized medium for haploidy maintenance. These findings benefit haploid stem cell‐based genetic screening analyses and deepen the understanding of MQC in mammalian cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Pluripotent Stem Cells Research · Mitochondrial Function and Pathology · Reproductive Biology and Fertility

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Medicinal Chemical Biology College of Pharmacy Nankai University Animal Resources Center and Reproductive Regulation and Institute of Transplantation Medicine Nankai University Tianjin China

Department of Neonatology Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorders Ministry of Education Key Laboratory of Child Development and Disorders China International Science and Technology Cooperation Base of Child Development and Critical Disorders Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity Chongqing China

Department of Obstetrics and Gynecology Chongqing Key Laboratory of Maternal and Fetal Medicine The First Affiliated Hospital of Chongqing Medical University Chongqing China

Funding

Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Natural Science Foundation of Tianjin Municipality

References (49)

Show source-provided references
1. 10.1038/nature1044810.1038/nature10448 ↗
2. 10.1038/nature1740810.1038/nature17408 ↗
3. 10.1016/j.stem.2013.11.01610.1016/j.stem.2013.11.016 ↗
4. 10.1016/j.cell.2012.04.00210.1016/j.cell.2012.04.002 ↗
5. 10.1016/j.stem.2013.12.00810.1016/j.stem.2013.12.008 ↗
6. 10.1016/j.stem.2011.10.01210.1016/j.stem.2011.10.012 ↗
7. 10.1371/journal.pbio.300035010.1371/journal.pbio.3000350 ↗
8. 10.1016/j.celrep.2015.06.06710.1016/j.celrep.2015.06.067 ↗
9. 10.1007/s13238‐019‐0625‐010.1007/s13238‐019‐0625‐0 ↗
10. 10.1016/j.csbj.2020.09.00610.1016/j.csbj.2020.09.006 ↗
11. 10.1038/s41598‐017‐13471‐410.1038/s41598‐017‐13471‐4 ↗
12. 10.1016/j.stemcr.2017.03.02510.1016/j.stemcr.2017.03.025 ↗
13. 10.1016/j.stemcr.2020.05.00410.1016/j.stemcr.2020.05.004 ↗
14. 10.1073/pnas.170513311410.1073/pnas.1705133114 ↗
15. 10.1016/j.stemcr.2020.11.01610.1016/j.stemcr.2020.11.016 ↗
16. 10.1038/s41556‐018‐0124‐110.1038/s41556‐018‐0124‐1 ↗
17. 10.1016/j.devcel.2021.02.00910.1016/j.devcel.2021.02.009 ↗
18. 10.1016/j.cmet.2013.06.00510.1016/j.cmet.2013.06.005 ↗
19. 10.3389/fcell.2020.0008710.3389/fcell.2020.00087 ↗
20. 10.1016/j.stem.2024.01.00910.1016/j.stem.2024.01.009 ↗
21. 10.1016/j.cell.2025.05.02010.1016/j.cell.2025.05.020 ↗
22. 10.1038/nature1143510.1038/nature11435 ↗
23. 10.1111/cpr.1349810.1111/cpr.13498 ↗
24. 10.3389/fcell.2020.0008710.3389/fcell.2020.00087 ↗
25. 10.1016/j.cmet.2015.06.00610.1016/j.cmet.2015.06.006 ↗
26. 10.1146/annurev‐pathmechdis‐012419‐03271110.1146/annurev‐pathmechdis‐012419‐032711 ↗
27. 10.1038/s42255‐023‐00930‐810.1038/s42255‐023‐00930‐8 ↗
28. 10.1038/s41571‐022‐00686‐210.1038/s41571‐022‐00686‐2 ↗
29. 10.1126/science.124700510.1126/science.1247005 ↗
30. 10.1038/cdd.2014.13910.1038/cdd.2014.139 ↗
31. 10.1038/s41467‐022‐31187‐610.1038/s41467‐022‐31187‐6 ↗
32. 10.1016/j.tibs.2019.11.00110.1016/j.tibs.2019.11.001 ↗
33. 10.1126/science.124299310.1126/science.1242993 ↗
34. 10.1093/gerona/glae08810.1093/gerona/glae088 ↗
35. 10.1038/s41586‐021‐03269‐w10.1038/s41586‐021‐03269‐w ↗
36. 10.1016/j.gene.2024.14897610.1016/j.gene.2024.148976 ↗
37. 10.1158/0008‐5472.CAN‐05‐045310.1158/0008‐5472.CAN‐05‐0453 ↗
38. 10.1126/sciadv.adw522810.1126/sciadv.adw5228 ↗
39. 10.18632/oncotarget.538610.18632/oncotarget.5386 ↗
40. 10.1016/j.freeradbiomed.2014.03.00310.1016/j.freeradbiomed.2014.03.003 ↗
41. 10.1038/s41586‐019‐1770‐610.1038/s41586‐019‐1770‐6 ↗
42. 10.1038/ncomms429510.1038/ncomms4295 ↗
43. 10.1016/j.stem.2016.10.00910.1016/j.stem.2016.10.009 ↗
44. 10.1038/nature0696810.1038/nature06968 ↗
45. 10.1038/nmeth.304710.1038/nmeth.3047 ↗
46. 10.1038/nprot.2017.01610.1038/nprot.2017.016 ↗
47. 10.1186/s13059‐014‐0554‐410.1186/s13059‐014‐0554‐4 ↗
48. 10.1038/s41596‐018‐0113‐710.1038/s41596‐018‐0113‐7 ↗
49. 10.1093/gpbjnl/qzag00510.1093/gpbjnl/qzag005 ↗